Kestra Medical Technologies, Ltd. (KMTS)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-KLatest | FY-2026 | 8-K (2026-07-14) · 99.1 | ||
| 10-QLatest | Q3-2026 | 8-K (2026-03-17) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-12-11) · 99.1 | 8-K (2025-12-01) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-09-11) · 99.1 | ||
| 10-K | FY-2025 | 8-K (2025-07-15) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-04-14) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Document and Entity Information | ||
| Statements | ||
| Condensed Balance Sheets of Kestra Medical Technologies, Ltd (unaudited) | — |
|
| Condensed Consolidated Balance Sheets | ||
| Condensed Balance Sheets of Kestra Medical Technologies, Ltd(unaudited) (P) | — |
|
| Condensed Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Consolidated Statements of Operations and Comprehensive Lossconsolidated Statements of Operations and Comprehensive Loss | — |
|
| Consolidated Statements of Changes In Redeemable Preferred Stock and Shareholders' Equity (deficit) | ||
| Consolidated Statements of Changes In Redeemable Preferred Stock and Shareholders' Equity (deficit) (P) | ||
| Condensed Consolidated Statements of Changes In Redeemable Preferred Stock and Stockholder's Deficit (unaudited) | — |
|
| Consolidated Statements of Cash Flows | ||
| Notes | ||
| Accrued Liabilities | ||
| Commitments and Contingencies | ||
| Commitments and Contingencies of Kestra Medical Technologies, Ltd. | — |
|
| Common Shares | ||
| Cybersecurity Risk Management, Strategy, and Governance Disclosure | — |
|
| Defined Contribution Plan | ||
| Description of Business of Kestra Medical Technologies, Ltd | — |
|
| Equity Incentive Plan | ||
| Equity Incentive Plan and Share Based Compensation | — |
|
| Equity Incentive Plan and Stock Based Compensation | — |
|
| Fair Value Measurement | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Leases | ||
| Long-term Debt | ||
| Nature of Operations and Liquidity | — |
|
| Net Loss Per Share Attributable To Common Shareholders | ||
| Net Loss Per Share Attributable To Common Stockholder | — |
|
| Non-controlling Interest | ||
| Pay Vs Performance Disclosure | ||
| Prepaid Expenses and Other Current Assets | ||
| Property and Equipment | ||
| Redeemable Preferred Stock | ||
| Shareholder's Equity of Kestra Medical Technologies, Ltd. | — |
|
| Significant Accounting Policies | ||
| Significant Accounting Policies of Kestra Medical Technologies, Ltd. | — |
|
| Stockholder's Deficit | — |
|
| Strategic Collaboration Agreement | — |
|
| Subsequent Event | ||
| Subsequent Events of Kestra Medical Technologies, Ltd. | — |
|
| The Company | ||